BioMarin Pharmaceutical, Inc. (BMRN)
54.38
-1.01
(-1.82%)
USD |
NASDAQ |
Oct 13, 16:00
54.38
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Return Price : 54.38 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 54.38 |
| October 12, 2026 | 55.39 |
| October 09, 2026 | 54.80 |
| October 08, 2026 | 54.89 |
| October 07, 2026 | 55.20 |
| October 06, 2026 | 56.22 |
| October 05, 2026 | 57.54 |
| October 02, 2026 | 57.18 |
| October 01, 2026 | 58.44 |
| September 30, 2026 | 60.00 |
| September 29, 2026 | 59.87 |
| September 28, 2026 | 59.46 |
| September 25, 2026 | 60.26 |
| September 24, 2026 | 61.35 |
| September 23, 2026 | 62.21 |
| September 22, 2026 | 63.37 |
| September 21, 2026 | 64.06 |
| September 18, 2026 | 63.94 |
| September 17, 2026 | 65.08 |
| September 16, 2026 | 64.73 |
| September 15, 2026 | 64.45 |
| September 14, 2026 | 66.41 |
| September 11, 2026 | 65.68 |
| September 10, 2026 | 65.51 |
| September 09, 2026 | 64.41 |
| Date | Value |
|---|---|
| September 08, 2026 | 64.63 |
| September 04, 2026 | 66.53 |
| September 03, 2026 | 66.43 |
| September 02, 2026 | 66.97 |
| September 01, 2026 | 64.84 |
| August 31, 2026 | 65.23 |
| August 28, 2026 | 64.66 |
| August 27, 2026 | 65.29 |
| August 26, 2026 | 65.61 |
| August 25, 2026 | 66.12 |
| August 24, 2026 | 65.07 |
| August 21, 2026 | 66.70 |
| August 20, 2026 | 67.68 |
| August 19, 2026 | 69.33 |
| August 18, 2026 | 66.99 |
| August 17, 2026 | 66.64 |
| August 14, 2026 | 67.36 |
| August 13, 2026 | 68.53 |
| August 12, 2026 | 70.24 |
| August 11, 2026 | 69.55 |
| August 10, 2026 | 68.88 |
| August 07, 2026 | 63.81 |
| August 06, 2026 | 61.46 |
| August 05, 2026 | 59.91 |
| August 04, 2026 | 60.72 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Ascendis Pharma A/S | 223.21 |
| Alnylam Pharmaceuticals, Inc. | 223.82 |
| Vertex Pharmaceuticals, Inc. | 485.22 |
| BridgeBio Pharma, Inc. | 63.30 |
| ACADIA Pharmaceuticals, Inc. | 18.62 |